In this study, DDIT3 was upregulated in the validated cohort of PAH patients, which is not consistant with our predicted results and requires further studies to understand the possible pathogenic mechanisms as a controversial point. This evidence concerns the gene DDIT3 and pulmonary arterial hypertension.